The global colorectal cancer therapeutics market is anticipated to grow at a CAGR of 5.8% during the forecast period (2023-2030). The market growth is attributed to increasing number of grants to expand quality initiatives focused on enhancing biomarker-directed therapy in metastatic colorectal cancer. In August 2023, the National Comprehensive Cancer Network® (NCCN®) Oncology...